SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-018849
Filing Date
2022-07-08
Accepted
2022-07-08 07:25:59
Documents
15
Period of Report
2022-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43223
2 ex4-1.htm EX-4.1 101115
3 ex10-1.htm EX-10.1 255813
4 ex4-1_001.jpg GRAPHIC 10027
  Complete submission text file 0001493152-22-018849.txt   666115

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prvb-20220707.xsd EX-101.SCH 2974
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prvb-20220707_lab.xml EX-101.LAB 34916
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prvb-20220707_pre.xml EX-101.PRE 22799
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38552 | Film No.: 221072829
SIC: 2834 Pharmaceutical Preparations